Pricing Log in Create free account

Acurx Pharmaceuticals, Inc. (ACXP) vs Heatwurx Inc. (PCSA)

Acurx Pharmaceuticals, Inc. and Heatwurx Inc. are both Biotechnology companies. Acurx Pharmaceuticals, Inc. and Heatwurx Inc. are of similar size ($5.3M and $5.1M). Across the 7 metrics below, Acurx Pharmaceuticals, Inc. leads on 5 and Heatwurx Inc. on 2.

Valuation

Metric ACXP PCSA Biotechnology median
P/E n/m n/m 10.60
P/S n/m 39.69 9.40
P/B 0.56 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.80 n/m 0.66
EV/Sales n/m 49.49 9.02
Earnings yield (290.18%) (299.98%) (32.88%)
Free cash flow yield (135.67%) (252.81%) (23.13%)

Profitability

Metric ACXP PCSA Biotechnology median
Gross margin — 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (128.11%) (464.19%) (51.96%)
Return on assets (87.57%) (262.17%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ACXP PCSA Biotechnology median
Revenue growth (TTM) — (34.50%) 6.76%
EPS growth (last fiscal year) 69.43% 89.29% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ACXP PCSA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.88 0.87 4.97
Net debt to EBITDA 0.93 0.40 1.01

Dividend

Metric ACXP PCSA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ACXP PCSA Biotechnology median
Market cap 5.26m 5.14m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack